Adam6 Mice

Patent No. EP2578688 (titled "Adam6 Mice") was filed by Regeneron Pharmaceuticals on Feb 24, 2012. The application was issued on Feb 8, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KYMABMay 4, 2020CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2578688

REGENERON PHARMACEUTICALS
Application Number
EP12192727A
Filing Date
Feb 24, 2012
Status
Patent Maintained As Amended
Jan 6, 2023
Publication Date
Feb 8, 2023